Patents/Assignees

ANBOGEN THERAPEUTICS, Inc

2 patents in portfolio

US12252469utility2025
Crystalline Forms of (e)-n-hydroxy-3-(1-(phenylsulfonyl)indolin-5-yl)acrylamide
0 cites
US12240858utility2025
Crystalline Forms of (S, E)-4-(dimethylamino)-n-(3-(4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2- Enamide Free Base
0 cites